Flying eye hospital heads to China

Article

ORBIS International's Flying Eye Hospital has completed an intensive two-week training programme for approximately 40 ophthalmology residents in Harbin, China.

ORBIS International’s Flying Eye Hospital has completed an intensive two-week training programme for approximately 40 ophthalmology residents in Harbin, China. Approximately 18% of the world’s blind live in China; up to 80% of the country’s ophthalmologists work in urban hospitals, although up to 80% of the 5–6 million blind people live in rural regions.

Although ORBIS frequently conducts training programmes in developing countries around the world, this is the first time the Flying Eye Hospital has been used to train only ophthalmic residency physicians. ORBIS conducted the programme at the request of Heilongjiang Provincial Government, Heilongjiang Provincial Health Bureau, and the Second Affiliated Hospital of Harbin Medical University.

The course, which focused on the treatment and management of paediatric strabismus, glaucoma and cataract (China’s leading cause of blindness), made use of hands-on surgical training, wet labs, live surgical demonstrations, surgical simulator sessions, lectures and workshops for training. ORBIS also conducted clinics on retinal disease and neuro-ophthalmology.

Approximately half of the medical equipment in China does not function correctly. In conjunction with the residents’ training course, ORBIS also repaired critical equipment and provided hands-on training for nine biomedical engineers and technicians, to combat the lack of functioning equipment and continuing education available in this region.

The ORBIS programme in Harbin was sponsored by Alcon, ORBIS’s Alliance for Sight partner.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.